LivaNova

LivaNova, PLC
Private
Traded as LSE: LIVN
NASDAQ: LIVN
Founded London, England, UK (2015)
Headquarters 5 Merchant Square
North Wharf Road
London W2 1AY
United Kingdom
Key people
 André-Michel Ballester,
Chief Executive Officer
Products Medical devices for cardiac surgery, neuromodulation and cardiac rhythm management
Website http://www.livanova.com

LivaNova, PLC is an London, England-based medical device manufacturer. The company develops devices used for cardiac surgery, neuromodulation and cardiac rhythm management. The company was formed by a 2015 $2.7B merger between Houston, TX-based Cyberonics, Inc. and Milan, Italy-based Sorin S.p.a.[1] The company trades on both the London Stock Exchange and NASDAQ.[2]

History

Cyberonics, Inc. was founded in Houston in 1987.[3] Sorin, also known as Sorin Group, was founded in 1956 by Fiat and Montedison, Italy's two largest industrial groups at that time. The name is an acronym for Società Ricerche Impianti Nucleari (Company for Nuclear Plant Research).[4] In March 2015, the companies announced they would be merging in a $2.7B transaction.[5] The transaction closed and the company began trading under the new stock symbol on Oct. 19. 2015.[1]

Business units

The new combined company announced in May 2015 that it was focused on three product categories and will operate as three business units. The three units are cardiac surgery, with its operating HQ in Italy, cardiac rhythm management, with its operating HQ in France, and neuromodulation, with its operating HQ in Houston.[5]

References

  1. 1 2 "Merged Houston company begins trading under new name". Houston Business Journal. 2015-10-19. Retrieved 2015-10-19.
  2. ↑ "Medical tech LivaNova debuts on London Stock Exchange". CNBC. 2015-10-19. Retrieved 2015-10-19.
  3. ↑ "Houston's Top Workplaces - 2012" (PDF). Houston Chronicle. 2012-11-11. Retrieved 2015-10-19.
  4. ↑ "From Fiat to heart valves". INSEAD. 2012-04-26. Retrieved 2015-10-19.
  5. 1 2 "Deal of the Week: Houston’s Cyberonics teams up with Italian firm for $2.7B". Houston Chronicle. 2015-05-06. Retrieved 2015-10-19.

External links

This article is issued from Wikipedia - version of the Tuesday, October 20, 2015. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.